Impact of polymorphisms in pharmacokinetic genes on tyrosine kinase inhibitor (TKI) tolerability in patients with chronic myeloid leukemia (CML) or Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL) Meeting Abstract
| Authors: | Patel, J. N.; Lopes, K. E.; Druhan, L. J.; Zeng, H.; Beam, T.; Moore, D. C.; Salem, A.; Hamadeh, I.; Savage, Q.; Chojecki, A. L.; Ai, J.; Knight, T. G.; Ragon, B. K.; Shah, N. A.; Sanikommu, S. R.; Steuerwald, N. M.; Smith, M.; Hamilton, A.; Rangavajhula, K.; Bell, A.; Drummond, K.; Symanowski, J. T.; Grunwald, M. R. |
| Abstract Title: | Impact of polymorphisms in pharmacokinetic genes on tyrosine kinase inhibitor (TKI) tolerability in patients with chronic myeloid leukemia (CML) or Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL) |
| Meeting Title: | 64th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 140 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2022 Dec 10-13 |
| Meeting Location: | New Orleans, LA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2022-11-15 |
| Start Page: | 11530 |
| End Page: | 11531 |
| Language: | English |
| ACCESSION: | WOS:000893230304292 |
| DOI: | 10.1182/blood-2022-166277 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
